Lilly's Jardiance meets main goal of two diabetes trials

(Reuters) - Eli Lilly&Co said on Monday that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing it in patients with type 1 diabetes.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

DiabetesMine provides a list of nine important things to know about your immune system with type 1 diabetes.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
Living with type 1 diabetes and having trouble sleeping? DiabetesMine has some ideas to help.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
Conditions:   Type 1 Diabetes;   type1diabetes;   Type 1 Diabetes Mellitus Interventions:   Dietary Supplement: Lactobacillus plantarum;   Other: Placebo Sponsor:   Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
(Joslin Diabetes Center) In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
The aim of the study was to establish whether suboptimal self-management explains the relationship between stressful life events and hemoglobin A1c (HbA1c) in adolescents with type 1 diabetes and whether these relationships differ across race/ethnicity.
Source: Journal of Adolescent Health - Category: Child Development Authors: Tags: Adolescent health brief Source Type: research
To evaluate the changes in cardiovascular risk factors (CVRFs) and cardiovascular disease (CVD) in patients with type 1 diabetes (T1D) and end-stage renal disease (ESRD) who were candidates for kidney-pancreas transplantation (KPTx) from 1999 to 2017.
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research
Conclusions/interpretationGAD-alum immunisation activates and propagates GAD-specific CD4 T cells with a distinctive bifunctional phenotype, the functional analysis of which might be important in understanding therapeutic responses.
Source: Diabetologia - Category: Endocrinology Source Type: research
Condition:   Diabetes Mellitus, Type 1 Interventions:   Drug: Dapagliflozin 5mg;   Drug: Placebo Sponsors:   The Hospital for Sick Children;   Canadian Institutes of Health Research (CIHR);   Juvenile Diabetes Research Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSIONS: Relaxation techniques as an adjunct to medical treatment are a useful tool for patients with type 1 diabetes mellitus. PMID: 32239448 [PubMed - as supplied by publisher]
Source: Hormones - Category: Endocrinology Tags: Hormones (Athens) Source Type: research
Conclusions: Overall, co-aggregation was more pronounced in monozygotic than in dizygotic twins, suggesting that disease overlap is largely attributable to genetic factors. Co-aggregation was common, and twins faced up to a ten-fold risk of developing diseases not present in their co-twin. Our results validate and refine previous heritability estimates based on smaller twin cohorts. PMID: 32229696 [PubMed - in process]
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Tags: Eur J Endocrinol Source Type: research
More News: Diabetes | Diabetes Type 1 | Empagliflozin | Endocrinology | Health | Insulin | Jardiance